0001055726-20-000056.txt : 20201217 0001055726-20-000056.hdr.sgml : 20201217 20201217190719 ACCESSION NUMBER: 0001055726-20-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIES PETER CENTRAL INDEX KEY: 0001259780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 201397535 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_160825002177388.xml FORM 4 X0306 4 2020-12-15 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001259780 KIES PETER C/O INOVIO PHARMACEUTICALS, INC. 6769 MESA RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 CFO Common Stock 2020-12-15 4 M 0 8750 2.40 A 128040 D Common Stock 2020-12-15 4 M 0 11250 2.16 A 139290 D Common Stock 2020-12-15 4 S 0 20000 10.6853 D 119290 D Common Stock 4500 I By Spouse Common Stock Option 2.4 2020-12-15 4 M 0 8750 0 D 2012-02-23 2022-02-23 Common Stock 8750.0 0 D Common Stock Option 2.16 2020-12-15 4 M 0 11250 0 D 2013-03-14 2023-03-14 Common Stock 11250.0 33750 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These transactions were executed in multiple trades at prices ranging from $10.52 to $10.83, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. Peter Kies 2020-12-17